TVB-3166 is an orally-available, reversible, and selective fatty acid synthase (FASN) inhibitor with IC 50 s of 42 nM and 81 nM for biochemical FASN and cellular palmitate synthesis, respectively. TVB-3166 induces apoptosis , and inhibits in-vivo xenograft tumor growth.